Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07645391 · ClinicalTrials.gov registry record
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Recruiting
- Registry status
- 200
- Enrollment target
NCT07645391 is a clinical trial that is actively recruiting participants, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 200 participants.
The verdict
NCT07645391 is actively recruiting participants, sponsored by University of Michigan Rogel Cancer Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07645391
The ClinicalTrials.gov registry entry for NCT07645391 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07645391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07645391 about?
NCT07645391 is a clinical study titled "Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer". This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.
What is the current status of trial NCT07645391?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2017-01-01. Estimated completion is 2030-01.
What interventions are being tested in trial NCT07645391?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07645391?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.